Overview
Carsten Marr practices practicing medicine in Munich, Germany.
His clinical expertise encompasses Leukemia, Acute Myeloid Leukemia (AML), and Myelodysplastic Syndrome (MDS).
He is actively involved in clinical research, co-authoring 89 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Carsten Marr
Is Carsten Marr a top-rated expert for Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Carsten Marr is classified as an Experienced expert for Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Carsten Marr participate in research or clinical trials?
Yes. Carsten Marr has published 89 articles and abstracts on conditions like Leukemia. You can view a list of Carsten Marr's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Myeloid Leukemia (AML)Mr. Marr isExperienced. Learn about Acute Myeloid Leukemia (AML).
- LeukemiaMr. Marr isExperienced. Learn about Leukemia.
- Myelodysplastic Syndrome (MDS)Mr. Marr isExperienced. Learn about Myelodysplastic Syndrome (MDS).